Cargando…
Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis
BACKGROUND: Since long non-coding RNA breast cancer anti-estrogen resistance 4 (lncRNA BCAR4) is dysregulated in various types of cancers, we conducted a meta-analysis to determine its prognostic value in cancer. METHODS: PubMed, EMBASE database, and CENTRAL were systematically searched. Pooled haza...
Autores principales: | Meng, Yang, Liu, Yu-Lan, Li, Kai, Fu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571273/ https://www.ncbi.nlm.nih.gov/pubmed/31124974 http://dx.doi.org/10.1097/MD.0000000000015793 |
Ejemplares similares
-
Prognostic value of long non-coding RNA SNHG20 in cancer: A meta-analysis
por: Zeng, Jiling, et al.
Publicado: (2020) -
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
por: Shen, Yi, et al.
Publicado: (2015) -
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2022) -
Meta-analysis of the prognostic value of long non-coding RNA PVT1 for cancer patients
por: Ma, Chao, et al.
Publicado: (2018) -
Prognostic value of long non-coding RNA CRNDE in gastrointestinal cancers: a meta-analysis
por: He, Tian-Yu, et al.
Publicado: (2019)